Filing Details
- Accession Number:
- 0001144204-13-030864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-21 17:46:06
- Reporting Period:
- 2013-05-17
- Filing Date:
- 2013-05-21
- Accepted Time:
- 2013-05-21 17:46:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1523662 | Binh Nguyen | 3000 Kent Avenue Suite A1-100 West Lafayette IN 47906 | Vp Of Clinical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-17 | 17,300 | $3.55 | 17,300 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-17 | 17,300 | $14.42 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-05-17 | 17,300 | $0.00 | 17,300 | $3.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
62,700 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.
- Represents the sale of 17,300 shares in multiple transactions, ranging in price from $14.41 to $14.4701 per share, resulting in a weighted average sale price per share of $14.42. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.